Tag: Hepatitis
Chronic Hepatitis B Virus Is Undertreated
Findings seen in global study of patients in nine countries
Prevalence of Hepatitis Delta High in Hepatitis B Surface Antigen Chronic Carriers
Cirrhosis may develop in more patients with detectable HDV RNA than in those without
Emergency Department Use Up for Alcohol-Associated Hepatitis
Recent increases seen for visits among younger people and those with higher disease severity
Antivirals Aid HBeAg-Negative Chronic Hepatitis B Patients
Findings seen for those with normal alanine transaminase and especially for patients with HBV DNA ≥2,000 IU/mL
Guideline Updated for Managing Hepatitis C in Chronic Kidney Disease
Authors recommend hepatitis C treatment with sofosbuvir-based regimens should be expanded, including to those receiving dialysis
Two-Week DAA Prophylaxis Prevents Hep C After Kidney Transplant
Two-week DAA optimal for preventing infection in individuals without HCV viremia who received kidney from HCV-viremia-positive donors
Direct-Acting Antivirals Still Underused in Hep C-Related Liver Cancer
Higher odds of receiving DAA treatment seen for younger age, being seen by a gastroenterologist or infectious disease physician, having cirrhosis
Hep C Testing Recommendations Developed for Perinatally Exposed Infants
Four recommendations include HCV testing of all perinatally exposed infants with nucleic acid testing for HCV RNA at age 2 to 6 months
Increase in Hepatitis A Vaccination Needed to Prevent Deaths
Nearly two-thirds with hepatitis A-related deaths had at least one documented indication for vaccination; only 4 percent vaccinated
Revaccination Suggested for Hep B Vaccine Nonresponders After Hep C Cure
Revaccination should be considered for patients with chronic HCV who do not respond to HBV vaccination
